Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Comparative sensitivity evaluation for 122 CE-marked SARS-CoV-2 antigen rapid tests

Heinrich Scheiblauer, Angela Filomena, Andreas Nitsche, Andreas Puyskens, Victor M Corman, Christian Drosten, Katrin Zwirglmaier, Constanze Lange, Petra Emmerich, Michael Müller, Olivia Knauer, View ORCID ProfileC Micha Nübling
doi: https://doi.org/10.1101/2021.05.11.21257016
Heinrich Scheiblauer
1Paul-Ehrlich-Institute, Paul-Ehrlich-Str. 51-59, D-63225 Langen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Angela Filomena
1Paul-Ehrlich-Institute, Paul-Ehrlich-Str. 51-59, D-63225 Langen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andreas Nitsche
2Robert Koch-Institute, Seestrasse 10, D-13353 Berlin
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andreas Puyskens
2Robert Koch-Institute, Seestrasse 10, D-13353 Berlin
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Victor M Corman
3Institute of Virology, Charite, Chariteplatz 1, D-10117 Berlin
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christian Drosten
3Institute of Virology, Charite, Chariteplatz 1, D-10117 Berlin
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Katrin Zwirglmaier
4Bundeswehr Institute of Microbiology, Neuherbergstr 11, D-80937 Munich
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Constanze Lange
5LADR GmbH, Lauenburger Str. 67, D-21502 Geesthacht
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Petra Emmerich
6Bernhard-Nocht Institute, Dep.Virology, Bernhard-Nocht Str. 74, D-20359 Hamburg
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Müller
7MVZ Labor 28 GmbH, Mecklenburgische Str. 2, D-14197 Berlin
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Olivia Knauer
1Paul-Ehrlich-Institute, Paul-Ehrlich-Str. 51-59, D-63225 Langen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
C Micha Nübling
1Paul-Ehrlich-Institute, Paul-Ehrlich-Str. 51-59, D-63225 Langen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for C Micha Nübling
  • For correspondence: micha.nuebling@pei.de
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Objective Independent evaluation of the sensitivity of CE-marked SARS-CoV-2 antigen rapid diagnostic tests (Ag RDT) offered in Germany.

Method The sensitivity of 122 Ag RDT was adressed using a common evaluation panel. Minimum sensitivity of 75% for panel members with CT<25 was used for differentiation of devices eligible for reimbursement in in the German healthcare system.

Results The sensitivity of different SARS-CoV-2 Ag RDT varied over a wide range. The sensitivity limit of 75% for panel members with CT <25 was met by 96 of the 122 tests evaluated; 26 tests exhibited lower sensitivity, few of which were completely failing. Some devices exhibited high sensitivity, e.g. 100% for CT<30.

Conclusion This comparative evaluation succeeded to distinguish less sensitive from better performing Ag RDT. Most of the Ag RDT evaluated appear to be suitable for fast identification of acute infections associated with high viral loads. Market access of SARS-CoV-2 Ag RDT should be based on minimal requirements for sensitivity and specificity.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

The study was funded by the German Ministry of Health. PEI is a governmental authority under the MOH. There was no other funding or payment received

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study obtained ethical approval by the Berliner Aerztekammer (Eth 20/40)

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • This study has been submitted as tandem manuscript together with the study of Puyskens A et al. “Establishment of an evaluation panel for the decentralized technical evaluation of the sensitivity of 31 rapid detection tests for SARS-CoV-2 diagnostics”

Data Availability

All relevant data are contained in the manuscript

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted May 12, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Comparative sensitivity evaluation for 122 CE-marked SARS-CoV-2 antigen rapid tests
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Comparative sensitivity evaluation for 122 CE-marked SARS-CoV-2 antigen rapid tests
Heinrich Scheiblauer, Angela Filomena, Andreas Nitsche, Andreas Puyskens, Victor M Corman, Christian Drosten, Katrin Zwirglmaier, Constanze Lange, Petra Emmerich, Michael Müller, Olivia Knauer, C Micha Nübling
medRxiv 2021.05.11.21257016; doi: https://doi.org/10.1101/2021.05.11.21257016
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Comparative sensitivity evaluation for 122 CE-marked SARS-CoV-2 antigen rapid tests
Heinrich Scheiblauer, Angela Filomena, Andreas Nitsche, Andreas Puyskens, Victor M Corman, Christian Drosten, Katrin Zwirglmaier, Constanze Lange, Petra Emmerich, Michael Müller, Olivia Knauer, C Micha Nübling
medRxiv 2021.05.11.21257016; doi: https://doi.org/10.1101/2021.05.11.21257016

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (271)
  • Allergy and Immunology (557)
  • Anesthesia (135)
  • Cardiovascular Medicine (1769)
  • Dentistry and Oral Medicine (238)
  • Dermatology (173)
  • Emergency Medicine (316)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (662)
  • Epidemiology (10812)
  • Forensic Medicine (8)
  • Gastroenterology (594)
  • Genetic and Genomic Medicine (2960)
  • Geriatric Medicine (288)
  • Health Economics (534)
  • Health Informatics (1933)
  • Health Policy (836)
  • Health Systems and Quality Improvement (745)
  • Hematology (293)
  • HIV/AIDS (633)
  • Infectious Diseases (except HIV/AIDS) (12525)
  • Intensive Care and Critical Care Medicine (696)
  • Medical Education (300)
  • Medical Ethics (87)
  • Nephrology (324)
  • Neurology (2808)
  • Nursing (152)
  • Nutrition (433)
  • Obstetrics and Gynecology (559)
  • Occupational and Environmental Health (597)
  • Oncology (1473)
  • Ophthalmology (444)
  • Orthopedics (172)
  • Otolaryngology (257)
  • Pain Medicine (190)
  • Palliative Medicine (56)
  • Pathology (381)
  • Pediatrics (868)
  • Pharmacology and Therapeutics (367)
  • Primary Care Research (338)
  • Psychiatry and Clinical Psychology (2646)
  • Public and Global Health (5383)
  • Radiology and Imaging (1016)
  • Rehabilitation Medicine and Physical Therapy (597)
  • Respiratory Medicine (727)
  • Rheumatology (330)
  • Sexual and Reproductive Health (290)
  • Sports Medicine (279)
  • Surgery (327)
  • Toxicology (48)
  • Transplantation (150)
  • Urology (126)